Body CompositionNCT07282275
How Does Continued Use of Green Light Therapy Impact Outcomes?
A study testing EmeraldLED in people with Body Composition, run by Efforia, Inc at 1 site in United States.
Trial summary
Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Body Composition
- What is being tested?
- EmeraldLED
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 21 Oct 2025to 21 Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Who cannot join
- Individuals with eye conditions
- Individuals not active with Green Light Therapy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Efforia
New York, New York, 10003
Matthew Amsden, (646) 679-2479, help@efforia.com
About this study
Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal.
Read the detailed description
This remotely administered decentralized trial is designed to meticulously investigate the effectiveness and potential benefits of green light therapy on body composition and overall well-being. As the wellness industry burgeons with claims of revolutionary treatments, the need for evidence-based research has never been more critical. Under the guidance of Ryan, the CEO of beem® Light Sauna, with an extensive background in the fitness and wellness industry, this study seeks to cut through the noise surrounding green light therapy. By leveraging the expansive network of beem®'s locations and their commitment to science-backed recovery modalities, this study aims to provide a robust evaluation of green light therapy's claims, focusing specifically on its impact on weight management and mood enhancement.
Participants in this study will engage in a series of green light therapy sessions, conducted entirely online to ensure convenience and broad accessibility. This innovative approach allows individuals from diverse geographical locations to partake in the study, enhancing the diversity of our participant pool and the generalizability of our findings. Throughout the study, participants will have their body composition meticulously analyzed, and their overall well-being assessed through scientifically validated measures, all from the comfort of their homes.
The primary objective of this investigation is to empower participants with tangible, personalized data concerning the effects of green light therapy on their health and wellness journey. By providing individualized feedback on changes in body composition and well-being, this study aims to illuminate the true efficacy of green light therapy. This endeavor not only seeks to validate or debunk existing claims but also to enrich the participant's understanding of their health, thereby enabling informed decisions regarding their wellness routines.
The significance of this study extends beyond the immediate benefits to the participants. By contributing to a pioneering exploration of green light therapy's potential in weight management and mood improvement, participants are at the forefront of a potentially transformative shift in health and wellness strategies. Although the study acknowledges limitations, including the necessity for subsequent comprehensive trials, the insights garnered here will pave the way for future health innovations. This trial stands as a beacon in the quest for truth, aiming to redefine approaches to weight management and wellness in an era increasingly focused on health consciousness.
- Conditions
- Body Composition
- Being tested
- EmeraldLED
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EmeraldLEDDevice
This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm².
The green light therapy provided in this study is set at 525 nm.
| Study group | Role | What they receive |
|---|---|---|
| Single arm where participants act as their own control | Experimental | Single Arm observational where participants act as their own control Receives: Device: EmeraldLED |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body Composition Measurement Form
The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.
Measured: Change from baseline (Day 1-3) in body composition at 4 weeks after the start of the intervention (Day 27-33).
Quality of Life and Health Survey
This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.
Measured: Change from baseline (Day 1-3) in quality of life and health at 4 weeks after the start of the intervention (Day 27-33).
Body Image and Self-Perception Survey
This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.
Measured: Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Dec 2025
- Study start21 Oct 2025
- Primary completion21 Oct 2026 (estimated)
- Study completion21 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Body CompositionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Single Arm observational where participants act as their own control
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Efforia, Inc
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07282275
- Sponsor's protocol ID
- 47409
- Status last verified
- Dec 2025
- First submitted
- 5 Dec 2025
- Last updated
- 23 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 23 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- How Does Continued Use of Green Light Therapy Impact Outcomes?
- ClinicalTrials.gov ID
- NCT07282275
- Acronym / sponsor ID
- 47409
- Conditions
- Body Composition
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Efforia, IncIndustry (pharma, biotech, devices)
- Study start
- 21 Oct 2025 (actual)
- Primary completion
- 21 Oct 2026 (estimated)
- Study completion
- 21 Oct 2026 (estimated)
- First posted
- 15 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal.
Detailed description
This remotely administered decentralized trial is designed to meticulously investigate the effectiveness and potential benefits of green light therapy on body composition and overall well-being. As the wellness industry burgeons with claims of revolutionary treatments, the need for evidence-based research has never been more critical. Under the guidance of Ryan, the CEO of beem® Light Sauna, with an extensive background in the fitness and wellness industry, this study seeks to cut through the noise surrounding green light therapy. By leveraging the expansive network of beem®'s locations and their commitment to science-backed recovery modalities, this study aims to provide a robust evaluation of green light therapy's claims, focusing specifically on its impact on weight management and mood enhancement.
Participants in this study will engage in a series of green light therapy sessions, conducted entirely online to ensure convenience and broad accessibility. This innovative approach allows individuals from diverse geographical locations to partake in the study, enhancing the diversity of our participant pool and the generalizability of our findings. Throughout the study, participants will have their body composition meticulously analyzed, and their overall well-being assessed through scientifically validated measures, all from the comfort of their homes.
The primary objective of this investigation is to empower participants with tangible, personalized data concerning the effects of green light therapy on their health and wellness journey. By providing individualized feedback on changes in body composition and well-being, this study aims to illuminate the true efficacy of green light therapy. This endeavor not only seeks to validate or debunk existing claims but also to enrich the participant's understanding of their health, thereby enabling informed decisions regarding their wellness routines.
The significance of this study extends beyond the immediate benefits to the participants. By contributing to a pioneering exploration of green light therapy's potential in weight management and mood improvement, participants are at the forefront of a potentially transformative shift in health and wellness strategies. Although the study acknowledges limitations, including the necessity for subsequent comprehensive trials, the insights garnered here will pave the way for future health innovations. This trial stands as a beacon in the quest for truth, aiming to redefine approaches to weight management and wellness in an era increasingly focused on health consciousness.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Single Arm observational where participants act as their own control
| Arm | Type | Receives |
|---|---|---|
| Single arm where participants act as their own control | Experimental | Device: EmeraldLEDSingle Arm observational where participants act as their own control |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Key exclusion criteria (2 listed)
- Individuals with eye conditions
- Individuals not active with Green Light Therapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EmeraldLEDThis device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm². The green light therapy provided in this study is set at 525 nm. | Device | Single arm where participants act as their own control |
Primary outcome
Body Composition Measurement Form
Time frame: Change from baseline (Day 1-3) in body composition at 4 weeks after the start of the intervention (Day 27-33).
The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.
Quality of Life and Health Survey
Time frame: Change from baseline (Day 1-3) in quality of life and health at 4 weeks after the start of the intervention (Day 27-33).
This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.
Body Image and Self-Perception Survey
Time frame: Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33).
This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Dec 2025.
- Additional information and join instructions on EfforiaLink provided by the sponsor.
Related trials for Body Composition
RecruitingObservational study
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Obesity & Overweight
Active, not recruiting
Effect of Exercise Training on Breastmilk Composition
Obesity
Not yet recruiting
Creatine and Muscle Health in Madrid's Walking Footballers.
Muscle Adaptation, Body Composition
RecruitingPhase 4
Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Mild Autonomous Cortisol Secretion (MACS)
RecruitingPhase 2/3
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
Type 1 Diabetes, Overweight , Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing EmeraldLED in people with Body Composition, run by Efforia, Inc at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Matthew Amsden (646-679-2479, help@efforia.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body Composition Measurement Form (time frame: Change from baseline (Day 1-3) in body composition at 4 weeks after the start of the intervention (Day 27-33).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.